REX-001
REX-001-004
Phase 3 small_molecule terminated
Quick answer
REX-001 for Peripheral Arterial Disease (PAD) is a Phase 3 program (small_molecule) at Design Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Peripheral Arterial Disease (PAD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated